Published mark
CVS Health
CVS HEALTH Corp
NYSE: CVS. CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services.
US
Record source reportedRecord not claimedNo Eval published
- Alpha ID
- alpha:company:73cf3305-e6ec-4b30-997b-fe6775bc66a4
- SEC CIK
- 0000064803
- Website
- www.cvshealth.com Open
- Record version
- vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce, published Oct 16, 2026
- Newest evidence
- May 3, 2026
- Monitoring
- Not yet monitored Details
- Integrity
- Not yet signed Methodology
- CEO
- J. David JoynerSince Feb 10, 2026
- Chair
- Not publishedLead independent: Michael F. Mahoney
- Independent
- Not published12 directors published
- Published claims
- 766 distinct sources
- Evidence records
- 270 pinned
- Source conflicts
- 0None open
Built from 6 distinct sources and 27 evidence records. Every Claim links to where it appears. Where nothing was published, the record states the coverage gap.
CorroboratedSource reportedAlpha inferenceNot disclosed
Public record. Alpha publishes governance facts about this organization from regulatory filings and company statements. Private enterprise overlay data is never projected here. The company can claim the record, correct, or dispute any Claim. How this works
EXECUTIVE APPOINTED
Amy Compton-Phillips executive of CVS Health, effective 2026-02-10.
EffectiveEffective Feb 10, 2026E17
Monitoring
ContinuousWhat the published record states about identity, evidence, evaluation, monitoring, authority, and freshness. Watched-source schedules are not published for this record.
- IdentityunclaimedPublished
- Evidencesource_reportedPublished
- Evaluationnot_evaluatedPublished
- MonitoringNot yet published for this record.Not published
- AuthorityNot yet published for this record.Not published
- FreshnesscurrentPublished
Leadership
Evidence| Role | Person | Since | Status | Claim |
|---|---|---|---|---|
| Executive Vice President and Chief Medical Officer | Amy Compton-Phillips | Feb 2026 | current | Source reportedE17 |
| Executive Vice President and Chief People Officer | Heidi B. Capozzi | Feb 2026 | current | Source reportedE19 |
| President and Chief Executive Officer | J. David Joyner | Feb 2026 | current | Source reportedE20 |
| Senior Vice President, Controller and Chief Accounting Officer | James D. Clark | Feb 2026 | current | Source reportedE21 |
| Executive Vice President and Group President | Prem S. Shah | Feb 2026 | current | Source reportedE22 |
| Executive Vice President, Chief Policy Officer and General Counsel | Samrat S. Khichi | Feb 2026 | current | Source reportedE23 |
| Executive Vice President and President, Aetna | Steven H. Nelson | Feb 2026 | current | Source reportedE24 |
| Executive Vice President, Ventures and Chief Experience and Technology Officer | Tilak Mandadi | Feb 2026 | current | Source reportedE25 |
| Executive Vice President and Chief Medical Officer | Amy Compton-Philips | Not captured | unknown | Source reportedE16 |
| Executive Vice President and Chief Financial Officer | Brian O. Newman | Not captured | unknown | Source reportedE18 |
Board of directors
Evidence12 directors published. Independence determinations are not published for every director.
| Director | Status | Since | Committees | Claim |
|---|---|---|---|---|
| Alecia A. DeCoudreaux | Independence not published | 2025 | Health Services and TechnologyHealth Services and Technology; Nominating and Corporate GovernanceNominating and Corporate Governance | Source reportedE3 |
| Anne M. Finucane | Independence not published | 2022 | CompensationESG, chairExecutiveManagement Planning and DevelopmentManagement Planning and Development; Public Policy and External Affairs; Executive; Compensation; ESG · ChairPublic Policy and External Affairs | Source reportedE4 |
| C. David Brown II | Independence not published | 2025 | Compensation, chairESGManagement Planning and DevelopmentManagement Planning and Development; Nominating and Corporate Governance; Public Policy and External Affairs; Compensation · Chair; ESGNominating and Corporate GovernancePublic Policy and External Affairs | Source reportedE5 |
| Douglas H. Shulman | Independence not published | 2025 | CompensationHealth Services and TechnologyHealth Services and Technology; Management Planning and Development; CompensationManagement Planning and Development | Source reportedE6 |
| Fernando Aguirre | Independence not published | 2018 | Audit, chairAudit · Chair; Management Planning and Development; CompensationCompensationManagement Planning and Development | Source reportedE7 |
| Guy P. Sansone | Independence not published | 2025 | AuditAudit; Nominating and Corporate GovernanceNominating and Corporate Governance | Source reportedE8 |
| J. David Joyner | Independence not published | 2025 | ESGExecutivePublic Policy and External AffairsPublic Policy and External Affairs; Executive; ESG | Source reportedE9 |
| J. Scott Kirby | Independence not published | 2025 | None published | Source reportedE10 |
| Jeffrey R. Balser, M.D., Ph.D. | Independence not published | 2025 | None published | Source reportedE11 |
| Larry M. Robbins | Independence not published | 2025 | None published | Source reportedE13 |
| Leslie V. Norwalk | Independence not published | 2025 | Health Services and TechnologyHealth Services and Technology; Public Policy and External AffairsPublic Policy and External Affairs | Source reportedE14 |
| Michael F. Mahoney | Independence not publishedLead Independent | 2025 | CompensationExecutiveManagement Planning and DevelopmentManagement Planning and Development; Nominating and Corporate Governance · Chair; Executive; CompensationNominating and Corporate Governance, chair | Source reportedE15 |
| J. Scott Kirby | Independence not published | Not published | Health Services and TechnologyNominating and Corporate Governance | Source reportedE26 |
| Jeffrey R. Balser | Independence not published | Not published | AuditExecutiveHealth Services and Technology, chair | Source reportedE26 |
| John E. Gallina | Independent | Not published | Audit | Source reportedE12 |
Committees and risk ownership
Evidence| Committee | Chair | Members | Risks assigned |
|---|---|---|---|
| Audit | Fernando Aguirre | Fernando Aguirre, Guy P. Sansone, Jeffrey R. Balser, John E. Gallina | Not described in the published record |
| Audit · Chair; Management Planning and Development; Compensation | Not published | Fernando Aguirre | Not described in the published record |
| Audit; Nominating and Corporate Governance | Not published | Guy P. Sansone | Not described in the published record |
| Compensation | C. David Brown II | C. David Brown II, Anne M. Finucane, Douglas H. Shulman, Fernando Aguirre, Michael F. Mahoney | Not described in the published record |
| ESG | Anne M. Finucane | Anne M. Finucane, C. David Brown II, J. David Joyner | Not described in the published record |
| Executive | Not published | Anne M. Finucane, J. David Joyner, Jeffrey R. Balser, Michael F. Mahoney | Not described in the published record |
| Health Services and Technology | Jeffrey R. Balser | Jeffrey R. Balser, Alecia A. DeCoudreaux, Douglas H. Shulman, J. Scott Kirby, Leslie V. Norwalk | Not described in the published record |
| Health Services and Technology; Management Planning and Development; Compensation | Not published | Douglas H. Shulman | Not described in the published record |
| Health Services and Technology; Nominating and Corporate Governance | Not published | Alecia A. DeCoudreaux | Not described in the published record |
| Health Services and Technology; Public Policy and External Affairs | Not published | Leslie V. Norwalk | Not described in the published record |
| Management Planning and Development | Not published | Anne M. Finucane, C. David Brown II, Douglas H. Shulman, Fernando Aguirre, Michael F. Mahoney | Not described in the published record |
| Management Planning and Development; Nominating and Corporate Governance · Chair; Executive; Compensation | Not published | Michael F. Mahoney | Not described in the published record |
| Management Planning and Development; Nominating and Corporate Governance; Public Policy and External Affairs; Compensation · Chair; ESG | Not published | C. David Brown II | Not described in the published record |
| Management Planning and Development; Public Policy and External Affairs; Executive; Compensation; ESG · Chair | Not published | Anne M. Finucane | Not described in the published record |
| Nominating and Corporate Governance | Michael F. Mahoney | Michael F. Mahoney, Alecia A. DeCoudreaux, C. David Brown II, Guy P. Sansone, J. Scott Kirby | Not described in the published record |
| Public Policy and External Affairs | Not published | Anne M. Finucane, C. David Brown II, J. David Joyner, Leslie V. Norwalk | Not described in the published record |
| Public Policy and External Affairs; Executive; ESG | Not published | J. David Joyner | Not described in the published record |
Committee AppointmentFernando Aguirre: chair, Audit
Committee AppointmentGuy P. Sansone: member, Audit
Committee AppointmentJeffrey R. Balser: member, Audit
Committee AppointmentJohn E. Gallina: member, Audit
Committee RecordCompensation: Chair C. David Brown II; Members C. David Brown II (Chair); Anne M. Finucane; Douglas H. Shulman; Fernando Aguirre; Michael F. Mahoney
Committee AppointmentC. David Brown II: chair, Compensation
Committee AppointmentAnne M. Finucane: member, Compensation
Committee AppointmentDouglas H. Shulman: member, Compensation
Committee AppointmentFernando Aguirre: member, Compensation
Committee AppointmentMichael F. Mahoney: member, Compensation
Committee RecordESG: Chair Anne M. Finucane; Members Anne M. Finucane (Chair); C. David Brown II; J. David Joyner
Committee AppointmentAnne M. Finucane: chair, ESG
Committee AppointmentC. David Brown II: member, ESG
Committee AppointmentJ. David Joyner: member, ESG
Committee RecordExecutive: Chair not stated; Members Anne M. Finucane; J. David Joyner; Jeffrey R. Balser; Michael F. Mahoney
Committee AppointmentAnne M. Finucane: member, Executive
Committee AppointmentJ. David Joyner: member, Executive
Committee AppointmentJeffrey R. Balser: member, Executive
Committee AppointmentMichael F. Mahoney: member, Executive
Committee AppointmentJeffrey R. Balser: chair, Health Services and Technology
Committee AppointmentAlecia A. DeCoudreaux: member, Health Services and Technology
Committee AppointmentDouglas H. Shulman: member, Health Services and Technology
Committee AppointmentJ. Scott Kirby: member, Health Services and Technology
Committee AppointmentLeslie V. Norwalk: member, Health Services and Technology
Committee RecordManagement Planning and Development: Chair not stated; Members Anne M. Finucane; C. David Brown II; Douglas H. Shulman; Fernando Aguirre; Michael F. Mahoney
Committee AppointmentAnne M. Finucane: member, Management Planning and Development
Committee AppointmentC. David Brown II: member, Management Planning and Development
Committee AppointmentDouglas H. Shulman: member, Management Planning and Development
Committee AppointmentFernando Aguirre: member, Management Planning and Development
Committee AppointmentMichael F. Mahoney: member, Management Planning and Development
Committee RecordNominating and Corporate Governance: Chair Michael F. Mahoney; Members Michael F. Mahoney (Chair); Alecia A. DeCoudreaux; C. David Brown II; Guy P. Sansone; J. Scott Kirby
Committee AppointmentMichael F. Mahoney: chair, Nominating and Corporate Governance
Committee AppointmentAlecia A. DeCoudreaux: member, Nominating and Corporate Governance
Committee AppointmentC. David Brown II: member, Nominating and Corporate Governance
Committee AppointmentGuy P. Sansone: member, Nominating and Corporate Governance
Committee AppointmentJ. Scott Kirby: member, Nominating and Corporate Governance
Committee RecordPublic Policy and External Affairs: Chair not stated; Members Anne M. Finucane; C. David Brown II; J. David Joyner; Leslie V. Norwalk
Committee AppointmentAnne M. Finucane: member, Public Policy and External Affairs
Committee AppointmentC. David Brown II: member, Public Policy and External Affairs
Committee AppointmentJ. David Joyner: member, Public Policy and External Affairs
Committee AppointmentLeslie V. Norwalk: member, Public Policy and External Affairs
Control and voting power
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Authority to act
Evidence and agent registryWho can act for the company, and on whose authority. This is what a counterparty's agent checks before it accepts an order, signs, or pays.
Principal executive officerJ. David Joyner, President and Chief Executive Officer, from Feb 10, 2026
Who can authorize an agentNot assessedNo Alpha inference about signing authority or board-reserved matters is published for this record.
Not assessed
AI agents registered by the companyNot registered in the public RegistryAgent Deployments, Agent Use Cases, Authority Grants, TrustChecks, Action Ledger entries and Governance Receipts live in the private enterprise overlay. They are never projected into the public Registry without explicit cross-plane authorization. Absence here is a plane boundary, not evidence that the enterprise operates no agents.
Agent registry
Delegations publishedNot disclosedBoard and officer delegation resolutions are not public filings and are not published in this record.
Search scope
Financials and market context
EvidenceIndex MembershipS&P 500 (SPX)
Security ListingCVS (NYSE)
Index memberships1 membership attached to a specific security and listing.Announcements, effective dates, and removals remain distinct states; Alpha does not infer membership from company size, exchange, or reputation.
SPX
Source reportedAs of Oct 16, 2026. Rights-filtered public evidence only; no redistribution or model training is granted. Only source-backed memberships with an explicit public redistribution basis are returned.
| Index | Security | Status | Effective | Verification | Source |
|---|---|---|---|---|---|
| S&P 500 (S&P Dow Jones Indices) | NYSE: CVS | current | Mar 4, 1957 | inferred | Slickcharts S&P 500 constituent table (public observation, not S&P DJI license) |
Governance and policies
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Risk, audit, and cyber
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
AI oversight and accountability
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Legal and regulatory
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Compensation
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Other published claims
EvidencePublished Claims that belong to no section above. Each keeps its permalink, evidence, and assertion state.
Legal NameCVS HEALTH Corp
Entity StatusPublic listing published
Official Websitehttps://www.cvshealth.com
Published FactUS
Published FactDE
Published FactHealthcare
Published FactMedical - Healthcare Plans
Published Facthttps://www.cvshealth.com
Not yet in this record
CoverageA gap is a coverage state, not a negative finding. These sections are expected for this entity class and are not yet published.
- Corporate structureNot reviewed. Parent, subsidiary and predecessor structure explains who is governed.
- OwnershipNot reviewed. Ownership and voting power determine who can influence the board.
- FinancialsNot reviewed. Governance-relevant financial context frames capital and audit decisions.
- CompensationNot reviewed. Pay design shows how incentives are governed.
- GovernanceNot reviewed. Governing documents and provisions set the rules of the enterprise.
- Shareholder governanceNot reviewed. Meeting and vote records show shareholder dissent and support.
- AuditNot reviewed. Auditor, controls and restatements show assurance over reporting.
- LegalNot reviewed. Material legal and regulatory matters show enforcement exposure.
- RiskNot reviewed. Risk ownership links the board, committees, executives and controls.
- CyberNot reviewed. Cyber and data governance is a disclosed oversight domain.
- AI governanceNot reviewed. AI oversight is a differentiated Alpha governance domain.
- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.This Company Profile is an identity and evidence record, not an Alpha rating.
Linked people
Same claims as person records- Amy Compton-PhillipsExecutive Vice President and Chief Medical Officercompany:73cf3305-e6ec-4b30-997b-fe6775bc66a4:leadership_role:24
- Heidi B. CapozziExecutive Vice President and Chief People Officercompany:73cf3305-e6ec-4b30-997b-fe6775bc66a4:leadership_role:26
- J. David JoynerPresident and Chief Executive Officer; Directorcompany:73cf3305-e6ec-4b30-997b-fe6775bc66a4:leadership_role:27, company:73cf3305-e6ec-4b30-997b-fe6775bc66a4:leadership_role:16
- James D. ClarkSenior Vice President, Controller and Chief Accounting Officercompany:73cf3305-e6ec-4b30-997b-fe6775bc66a4:leadership_role:28
- Prem S. ShahExecutive Vice President and Group Presidentcompany:73cf3305-e6ec-4b30-997b-fe6775bc66a4:leadership_role:29
- Samrat S. KhichiExecutive Vice President, Chief Policy Officer and General Counselcompany:73cf3305-e6ec-4b30-997b-fe6775bc66a4:leadership_role:30
- Steven H. NelsonExecutive Vice President and President, Aetnacompany:73cf3305-e6ec-4b30-997b-fe6775bc66a4:leadership_role:31
- Tilak MandadiExecutive Vice President, Ventures and Chief Experience and Technology Officercompany:73cf3305-e6ec-4b30-997b-fe6775bc66a4:leadership_role:32
- Amy Compton-PhilipsExecutive Vice President and Chief Medical Officercompany:73cf3305-e6ec-4b30-997b-fe6775bc66a4:leadership_role:23
- Brian O. NewmanExecutive Vice President and Chief Financial Officercompany:73cf3305-e6ec-4b30-997b-fe6775bc66a4:leadership_role:25
- Alecia A. DeCoudreauxDirectorcompany:73cf3305-e6ec-4b30-997b-fe6775bc66a4:leadership_role:10
- Anne M. FinucaneDirectorcompany:73cf3305-e6ec-4b30-997b-fe6775bc66a4:leadership_role:11
- C. David Brown IIDirectorcompany:73cf3305-e6ec-4b30-997b-fe6775bc66a4:leadership_role:12
- Douglas H. ShulmanDirectorcompany:73cf3305-e6ec-4b30-997b-fe6775bc66a4:leadership_role:13
- Fernando AguirreDirectorcompany:73cf3305-e6ec-4b30-997b-fe6775bc66a4:leadership_role:14
- Guy P. SansoneDirectorcompany:73cf3305-e6ec-4b30-997b-fe6775bc66a4:leadership_role:15
- J. Scott KirbyDirectorcompany:73cf3305-e6ec-4b30-997b-fe6775bc66a4:leadership_role:17
- Jeffrey R. Balser, M.D., Ph.D.Directorcompany:73cf3305-e6ec-4b30-997b-fe6775bc66a4:leadership_role:18
- Larry M. RobbinsDirectorcompany:73cf3305-e6ec-4b30-997b-fe6775bc66a4:leadership_role:20
- Leslie V. NorwalkDirectorcompany:73cf3305-e6ec-4b30-997b-fe6775bc66a4:leadership_role:21
- Michael F. MahoneyLead Independent Directorcompany:73cf3305-e6ec-4b30-997b-fe6775bc66a4:leadership_role:22
- J. Scott KirbyDirector (committee appointment)company:73cf3305-e6ec-4b30-997b-fe6775bc66a4:committee_record:53
- Jeffrey R. BalserDirector (committee appointment)company:73cf3305-e6ec-4b30-997b-fe6775bc66a4:committee_record:33
- John E. GallinaIndependent Directorcompany:73cf3305-e6ec-4b30-997b-fe6775bc66a4:leadership_role:19
Subject and corrections
Public-role doctrineThis record exists because the company is in the published Registry. The company can claim the record, correct, or dispute any Claim. Corrections are versioned and the original stays in history.
- Basis
- Published company record built from public sources
- Sources
- 27 evidence records cited. 0 with redistribution rights.
- Never published
- Private enterprise overlay data: deployments, authority grants, TrustChecks, receipts, telemetry
- Record claimed
- No
- Open disputes
- 0
- Identity ownership
- unclaimed
Claiming not yet available
If the company claims the record, its statements appear as their own assertion state and never overwrite the cited evidence.
Evidence
Authority and rights- E1Alpha canonical company public projection. canonical identity. Retrieved Oct 16, 2026. Cited by 7 Claims.
- E2CVS HEALTH Corp Form 10-K (filed 2026-02-10). SEC filing. Retrieved Aug 29, 2026. Cited by 2 Claims.
- E3sec filing. Published Apr 4, 2025. Retrieved May 15, 2026. Cited by 1 Claim.
- E4sec filing. Published Apr 3, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
- E5sec filing. Published Apr 4, 2025. Retrieved May 15, 2026. Cited by 1 Claim.
- E6sec filing. Published Apr 4, 2025. Retrieved May 15, 2026. Cited by 1 Claim.
- E7sec filing. Published Apr 3, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
- E8sec filing. Published Apr 4, 2025. Retrieved May 15, 2026. Cited by 1 Claim.
- E9sec filing. Published Apr 4, 2025. Retrieved May 15, 2026. Cited by 1 Claim.
- E10sec filing. Published Apr 4, 2025. Retrieved May 15, 2026. Cited by 1 Claim.
- E11sec filing. Published Apr 4, 2025. Retrieved May 15, 2026. Cited by 1 Claim.
- E12sec proxy. Published Apr 3, 2026. Retrieved Apr 5, 2026. Cited by 1 Claim.
- E13sec filing. Published Apr 4, 2025. Retrieved May 15, 2026. Cited by 1 Claim.
- E14sec filing. Published Apr 4, 2025. Retrieved May 15, 2026. Cited by 1 Claim.
- E15sec filing. Published Apr 4, 2025. Retrieved May 15, 2026. Cited by 1 Claim.
- E16CVS executive roster sourcesec filing. Published May 3, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
- E17sec filing. Published Feb 10, 2026. Retrieved May 14, 2026. Cited by 1 Claim.
- E18CVS executive roster sourcesec filing. Published May 3, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
- E19sec filing. Published Feb 10, 2026. Retrieved May 14, 2026. Cited by 1 Claim.
- E20sec filing. Published Feb 10, 2026. Retrieved May 14, 2026. Cited by 1 Claim.
- E21sec filing. Published Feb 10, 2026. Retrieved May 14, 2026. Cited by 1 Claim.
- E22sec filing. Published Feb 10, 2026. Retrieved May 14, 2026. Cited by 1 Claim.
- E23sec filing. Published Feb 10, 2026. Retrieved May 14, 2026. Cited by 1 Claim.
- E24sec filing. Published Feb 10, 2026. Retrieved May 14, 2026. Cited by 1 Claim.
- E25sec filing. Published Feb 10, 2026. Retrieved May 14, 2026. Cited by 1 Claim.
- E26board_seats. sp500-board-director-completeness-remediation-2026-05-15. Cited by 43 Claims.
- E27Slickcharts S&P 500 constituent table (public observation, not S&P DJI license). index provider. Retrieved Sep 2, 2026. Cited by 1 Claim.
What changed in version public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce
vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce published Oct 16, 2026- Amy Compton-Phillips executive of CVS Health, effective 2026-02-10.
- Heidi B. Capozzi executive of CVS Health, effective 2026-02-10.
- J. David Joyner executive of CVS Health, effective 2026-02-10.
- James D. Clark executive of CVS Health, effective 2026-02-10.
- Prem S. Shah executive of CVS Health, effective 2026-02-10.
- Samrat S. Khichi executive of CVS Health, effective 2026-02-10.
- Steven H. Nelson executive of CVS Health, effective 2026-02-10.
- Tilak Mandadi executive of CVS Health, effective 2026-02-10.
- Alecia A. DeCoudreaux seat on CVS Health, effective 2025-04-04.
- C. David Brown II seat on CVS Health, effective 2025-04-04.
- Douglas H. Shulman seat on CVS Health, effective 2025-04-04.
- Guy P. Sansone seat on CVS Health, effective 2025-04-04.
- J. David Joyner seat on CVS Health, effective 2025-04-04.
- J. Scott Kirby seat on CVS Health, effective 2025-04-04.
- Jeffrey R. Balser, M.D., Ph.D. seat on CVS Health, effective 2025-04-04.
- Larry M. Robbins seat on CVS Health, effective 2025-04-04.
- Leslie V. Norwalk seat on CVS Health, effective 2025-04-04.
- Michael F. Mahoney seat on CVS Health, effective 2025-04-04.
- Michael F. Mahoney lead independent director of CVS Health, effective 2025-04-04.
- Audit; Nominating and Corporate Governance committee of CVS Health, effective 2025-04-04.
- Guy P. Sansone member of Audit; Nominating and Corporate Governance, effective 2025-04-04.
- Health Services and Technology; Management Planning and Development; Compensation committee of CVS Health, effective 2025-04-04.
- Douglas H. Shulman member of Health Services and Technology; Management Planning and Development; Compensation, effective 2025-04-04.
- Health Services and Technology; Nominating and Corporate Governance committee of CVS Health, effective 2025-04-04.
- Alecia A. DeCoudreaux member of Health Services and Technology; Nominating and Corporate Governance, effective 2025-04-04.
- Health Services and Technology; Public Policy and External Affairs committee of CVS Health, effective 2025-04-04.
- Leslie V. Norwalk member of Health Services and Technology; Public Policy and External Affairs, effective 2025-04-04.
- Management Planning and Development; Nominating and Corporate Governance · Chair; Executive; Compensation committee of CVS Health, effective 2025-04-04.
- Michael F. Mahoney member of Management Planning and Development; Nominating and Corporate Governance · Chair; Executive; Compensation, effective 2025-04-04.
- Management Planning and Development; Nominating and Corporate Governance; Public Policy and External Affairs; Compensation · Chair; ESG committee of CVS Health, effective 2025-04-04.
- C. David Brown II member of Management Planning and Development; Nominating and Corporate Governance; Public Policy and External Affairs; Compensation · Chair; ESG, effective 2025-04-04.
- Public Policy and External Affairs; Executive; ESG committee of CVS Health, effective 2025-04-04.
- J. David Joyner member of Public Policy and External Affairs; Executive; ESG, effective 2025-04-04.
- Anne M. Finucane seat on CVS Health, effective 2022-01-01.
- Management Planning and Development; Public Policy and External Affairs; Executive; Compensation; ESG · Chair committee of CVS Health, effective 2022-01-01.
- Anne M. Finucane member of Management Planning and Development; Public Policy and External Affairs; Executive; Compensation; ESG · Chair, effective 2022-01-01.
- Fernando Aguirre seat on CVS Health, effective 2018-01-01.
- Audit · Chair; Management Planning and Development; Compensation committee of CVS Health, effective 2018-01-01.
- Fernando Aguirre member of Audit · Chair; Management Planning and Development; Compensation, effective 2018-01-01.